Combination Chemotherapy in Advanced Adrenocortical Carcinoma

Massimo Terzolo, Bruno Allolio, Éric Baudin, +32

New England Journal of Medicine

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Alfredo Berruti, Eric Baudin, Hans Gelderblom, +3

Annals of Oncology

Adrenal GlandUrologySurgical OncologyMedicineAdrenal Cancer +6

Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study

I G C Hermsen, Massimo Terzolo, Saskia Houterman, +9

The Journal of Clinical Endocrinology & Metabolism

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

Paola Sperone, Annamaria Ferrero, Fulvia Daffara, +16

Endocrine Related Cancer

Advanced Acc ProgressingSecond-/third-line ChemotherapyAdrenocortical CarcinomaMedicineMetronomic Therapy +11

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

Alfredo Berruti, Paola Sperone, Annamaria Ferrero, +12

European Journal of Endocrinology

Multimodal management of stages III–IVa malignant thymoma

S. Bretti, Alfredo Berruti, C Loddo, +11

Lung Cancer

Surgical OncologyMedicineMultimodal ManagementMultimodalityOncology +2

Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer¹

Massimo Terzolo, Anna Pia, Alfredo Berruti, +6

The Journal of Clinical Endocrinology & Metabolism

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

Paolo G. Casali, Paolo Bruzzi, Jan Bogaerts, +60

Annals of Oncology

Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma.

Annamaria Ferrero, Paola Sperone, Arianna Ardito, +7

PubMed

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation

Andrea Saini, Alfredo Berruti, Paola Sperone, +4

The Lancet Oncology

InflammationPegylated Liposomal DoxorubicinAnti-inflammatoryMedicineCutaneous Biology +8